Skip to content
Welcome To Our Store.
100,000+ Products for Home, Medical, Office & Classroom Needs
Search
Skip to product information
1 of 1

Therapeutic Monoclonal Antibodies and Antibody Products, Their Optimization and Drug Design in Cancers - Hardcover

$83.52 USD
$83.52 USD
Sale Sold out
Shipping calculated at checkout.
In stock (100 units), ready to be shipped

Available Offers

Fastest Delivery Tomorrow With Vip DealOrder within 1 hr 8 mins.

Instant 10% Discount On HDFC Banks Credit/Debit Cards EMI and CreditCard

Secure checkout with
  • American Express
  • Apple Pay
  • Diners Club
  • Discover
  • Google Pay
  • Mastercard
  • PayPal
  • Shop Pay
  • Visa

Flight Range: Up to 1,000 meters (3,280 feet)

Maximum Speed: 45 kilometers per hour (28 miles per hour)

For all orders exceeding a value of 100USD shipping is offered for free.

Returns will be accepted for up to 10 days of Customer’s receipt or tracking number on unworn items. You, as a Customer, are obliged to inform us via email before you return the item.

Otherwise, standard shipping charges apply. Check out our delivery Terms & Conditions for more details.

View Product Details
Shopping cart
Product Product subtotal Quantity Price Product subtotal
Therapeutic Monoclonal Antibodies and Antibody Products, Their Optimization and Drug Design in Cancers - Hardcover
Therapeutic Monoclonal Antibodies and Antibody Products, Their Optimization and Drug Design in Cancers - Hardcover
Therapeutic Monoclonal Antibodies and Antibody Products, Their Optimization and Drug Design in Cancers - Hardcover
$83.52/ea
$0.00
$83.52/ea $0.00

Product Description

by Veysel Kayser (Guest Editor)

The book broadly deals with therapeutic monoclonal antibodies (mAbs) and various relevant topics, including different antibody formats such as Antibody-Drug Conjugates (ADC), bispecifics, nanoparticle-based mAbs and HER2+ cancers, immune checkpoint inhibitors and other closely related topics. Each paper was written by leading active research groups in their fields both from academia and industry. The book should be of interest to those scientists and researchers who develop or use biologics, biotherapeutics, biosimilars and biobetters in cancer treatment.

Number of Pages: 298
Dimensions: 0.94 x 9.61 x 6.69 IN
Publication Date: January 25, 2022
you might like